Fig. 9

Kaplan-Meier survival curves for patients with (blue line, group 1) and without (yellow dashed line, group 2) thymus enlargement after CAR T cell treatment protocol. a) Patients with thymus enlargement after CAR T-cell treatment showed prolonged survival compared to patients without thymus enlargement (p = 0.017). b) Patients with thymus enlargement after CAR T-cell treatment showed higher event-free survival compared to patients without thymus enlargement (p = 0.003).